Compton Wealth Advisory Group LLC lowered its holdings in Oracle Corporation (NYSE:ORCL - Free Report) by 17.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 16,080 shares of the enterprise software provider's stock after selling 3,302 shares during the quarter. Compton Wealth Advisory Group LLC's holdings in Oracle were worth $2,248,000 as of its most recent filing with the SEC.
Several other institutional investors also recently made changes to their positions in ORCL. Whelan Financial raised its holdings in Oracle by 21.3% during the first quarter. Whelan Financial now owns 2,258 shares of the enterprise software provider's stock worth $316,000 after purchasing an additional 397 shares during the last quarter. Burke & Herbert Bank & Trust Co. increased its position in shares of Oracle by 5.2% in the first quarter. Burke & Herbert Bank & Trust Co. now owns 8,225 shares of the enterprise software provider's stock valued at $1,150,000 after buying an additional 406 shares in the last quarter. Sharp Financial Services LLC acquired a new position in shares of Oracle during the 1st quarter worth $204,000. Novare Capital Management LLC grew its stake in Oracle by 5.0% in the 1st quarter. Novare Capital Management LLC now owns 5,120 shares of the enterprise software provider's stock valued at $716,000 after acquiring an additional 245 shares during the last quarter. Finally, Adell Harriman & Carpenter Inc. grew its stake in Oracle by 0.8% in the 1st quarter. Adell Harriman & Carpenter Inc. now owns 87,202 shares of the enterprise software provider's stock valued at $12,192,000 after acquiring an additional 723 shares during the last quarter. 42.44% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Oracle news, Director Leon E. Panetta sold 17,500 shares of the company's stock in a transaction dated Friday, May 2nd. The shares were sold at an average price of $151.24, for a total value of $2,646,700.00. Following the completion of the transaction, the director owned 58,090 shares in the company, valued at approximately $8,785,531.60. This represents a 23.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Clayton M. Magouyrk sold 15,000 shares of the company's stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $214.10, for a total transaction of $3,211,500.00. Following the completion of the transaction, the insider owned 60,722 shares of the company's stock, valued at approximately $13,000,580.20. This trade represents a 19.81% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 440,366 shares of company stock valued at $83,103,603 in the last 90 days. Corporate insiders own 42.20% of the company's stock.
Analyst Upgrades and Downgrades
ORCL has been the subject of a number of research reports. Oppenheimer restated an "outperform" rating on shares of Oracle in a research report on Wednesday, June 18th. Barclays restated an "overweight" rating and set a $221.00 price objective (up from $202.00) on shares of Oracle in a research report on Friday, June 13th. TD Cowen upped their target price on Oracle from $250.00 to $275.00 and gave the company a "buy" rating in a research note on Thursday. Piper Sandler reissued a "neutral" rating and set a $130.00 price target on shares of Oracle in a research report on Wednesday, June 11th. Finally, UBS Group set a $250.00 price objective on Oracle and gave the company a "buy" rating in a research report on Wednesday, June 25th. Ten equities research analysts have rated the stock with a hold rating, twenty-two have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Oracle currently has an average rating of "Moderate Buy" and an average price target of $204.15.
Read Our Latest Research Report on ORCL
Oracle Stock Down 2.1%
Shares of NYSE:ORCL traded down $5.02 during midday trading on Monday, reaching $232.30. The company had a trading volume of 16,061,923 shares, compared to its average volume of 10,185,362. The stock's fifty day moving average price is $178.14 and its 200-day moving average price is $164.22. The stock has a market capitalization of $652.49 billion, a P/E ratio of 53.53, a PEG ratio of 3.55 and a beta of 1.39. Oracle Corporation has a one year low of $118.86 and a one year high of $237.99. The company has a debt-to-equity ratio of 4.07, a current ratio of 0.75 and a quick ratio of 0.75.
Oracle (NYSE:ORCL - Get Free Report) last released its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.06. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The firm had revenue of $15.90 billion during the quarter, compared to analyst estimates of $15.58 billion. During the same quarter in the previous year, the firm earned $1.63 earnings per share. The firm's revenue for the quarter was up 11.3% compared to the same quarter last year. Equities research analysts expect that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 24th. Investors of record on Thursday, July 10th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, July 10th. This represents a $2.00 dividend on an annualized basis and a yield of 0.86%. Oracle's payout ratio is currently 46.08%.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report